This study aims to explore the effect of Bacillus amyloliquefaciens-derived nonapeptide (BAP) on growth and immune function in cyclophosphamide (Cy)-induced immunosuppressed mice. The results showed that BAP alleviated the reduction of the body weight, daily feed intake and spleen and thymus index caused by Cy, and restored jejunal tissue morphology, goblet cell numbers and tight junction proteins. BAP enhanced the expression of immunoglobulins, including immunoglobulin M (IgM), immunoglobulin G (IgG) and secretory immunoglobulin A (SIgA), jejunal CD3+, CD4+ and CD8+ lymphocytes, and cytokines including interleukin-2 (IL-2) and interferon-γ (IFN-γ), while it inhibited the expression of interleukin-4 (IL-4) and interleukin-10 (IL-10). The oxidative stress and decreased antioxidant enzymes induced by Cy were also reversed by BAP. Moreover, BAP modulated the structure of gut microbiota and promoted the colonization of potential intestinal probiotics. Our findings establish the groundwork for comprehending the function of BAP and its potential utilization as an immunomodulator.
Full Text Finder